Catherine Ramsey
Stock Analyst at Baird
(4.09)
# 504
Out of 5,090 analysts
53
Total ratings
56.1%
Success rate
13.39%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Outperform | $39 → $41 | $38.65 | +6.08% | 9 | Nov 4, 2025 | |
| RVTY Revvity | Maintains: Outperform | $122 → $123 | $100.79 | +22.04% | 6 | Oct 28, 2025 | |
| ILMN Illumina | Maintains: Neutral | $84 → $105 | $128.96 | -18.58% | 6 | Jul 28, 2025 | |
| WAT Waters | Maintains: Outperform | $374 → $352 | $394.81 | -10.84% | 11 | Jul 16, 2025 | |
| TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $32.30 | +36.22% | 7 | May 6, 2025 | |
| NTRA Natera | Maintains: Outperform | $183 → $188 | $244.55 | -23.12% | 6 | Feb 28, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $572.77 | +16.10% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $145.49 | +9.97% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $101.06 | -25.79% | 1 | Aug 3, 2022 |
Castle Biosciences
Nov 4, 2025
Maintains: Outperform
Price Target: $39 → $41
Current: $38.65
Upside: +6.08%
Revvity
Oct 28, 2025
Maintains: Outperform
Price Target: $122 → $123
Current: $100.79
Upside: +22.04%
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $128.96
Upside: -18.58%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $394.81
Upside: -10.84%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $32.30
Upside: +36.22%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $244.55
Upside: -23.12%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $572.77
Upside: +16.10%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $145.49
Upside: +9.97%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $101.06
Upside: -25.79%